Vestibular schwannoma (VS) is a benign tumor that originates from Schwann cells in the
vestibular component. Surgical treatment for VS has gradually declined over the past few …

Vestibular schwannoma is a clinically benign schwannoma that arises from the
vestibulocochlear nerve that causes sensorineural hearing loss. This tumor is clinically and …

Background Prospective data on maintenance therapy with bevacizumab for persons with
NF2-related schwannomatosis (NF2-SWN) is lacking. In this prospective multicenter phase II …

Objective To review the literature on the diagnosis and treatment of vestibular schwannoma.
Methods: Task force members were educated on knowledge synthesis methods, including …

Abstract Background/Objectives: NF2-related schwannomatosis (NF2) is a tumor
predisposition syndrome that typically presents with bilateral vestibular schwannomas …

Hearing loss is a common side effect of many tumor treatments. However, hearing loss can
also occur as a direct result of certain tumors of the nervous system, the most common of …

The three types of neurofibromatosis, namely type 1, type 2, and schwannomatosis, are
generally associated with various benign tumors affecting the skin and the nervous system …

Schwannomas are tumors derived from Schwann-lineage cells, cells that protect and
support myelinated nerves in the peripheral nervous system. They are typically slow …

Objective To provide detailed guidance on the administration of systemic bevacizumab in
patients with recurrent respiratory papillomatosis (RRP) based on a detailed review of the …

Vestibular schwannomas (VSs) are tumors of Schwann cell origin which are histologically
benign, but clinically significant as hearing loss, facial weakness paralysis, and …